SHR-2173 injection
SHR-2173 injection is a pharmaceutical drug with 6 clinical trials. Currently 5 active trials ongoing.
Success Metrics
Phase Distribution
Phase Distribution
1
Early Stage
5
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
0.0%
0 of 0 finished
0.0%
0 ended early
5
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
Clinical Trials (6)
A Phase II Study of SHR-2173 Injection in Patients With Myasthenia Gravis
Phase I Study of SHR-2173 Injection in Patients With Primary Immune Thrombocytopenia
A Study of SHR-2173 in Participants With Primary IgA Nephropathy
A Study of SHR-2173 in Participants With Systemic Lupus Erythematosus
Phase II Randomized, Open-label, Multicenter Clinical Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of SHR-2173 Injection in Patients With Primary Membranous Nephropathy
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6